HDLForum

What's New

• Do dysfunctional HDL mediate the increased risk of atherosclerosis from traffic pollution?
• HDL: predictive of risk for infection in ischaemic stroke?
• ASSURE on course: RVX-208 in high-risk patients

Viewpoints

The HDL hypothesis: do recent trials with niacin add anything?

A position statement from HDL Forum Editor, Professor Philip Barter

Read more

Hot Topic

Following the HPS2-THRIVE announcement there has been much speculation about niacin and HDL. Now it is time to bring some balance to the debate.

According to Professor John Chapman, Past-President of the European Atherosclerosis Society, INSERM, Hôpital de la Pitié, Paris, France:

'First and foremost we must not forget that in addition to raising HDL cholesterol, niacin also lowers atherogenic lipoproteins, including LDL cholesterol, triglycerides and lipoprotein(a). Clearly, HPS2-THRIVE is NOT a test of the HDL hypothesis.'

Forthcoming Meetings

16-18 May, 2013: Heart Foundation Conference 2013
Adelaide, Australia
More Information

17-19 May , 2013: 8th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress
Marrakech, Morocco
More Information

May 30 - June 2, 2013: NLA Scientific Sessions
Las Vegas, USA
More Information

2-5 June, 2013: 81st Congress of the European Atherosclerosis Society
Lyon, France
More Information